7 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33707115 | Shikonin-mediated PD-L1 degradation suppresses immune evasion in pancreatic cancer by inhibiting NF-κB/STAT3 and NF-κB/CSN5 signaling pathways. | 2021 Apr | 5 |
2 | 32272431 | Shikonin mitigates ovariectomy-induced bone loss and RANKL-induced osteoclastogenesis via TRAF6-mediated signaling pathways. | 2020 Jun | 2 |
3 | 32473224 | Shikonin relieves osteoporosis of ovariectomized mice by inhibiting RANKL-induced NF-κB and NFAT pathways. | 2020 Sep 1 | 2 |
4 | 32952636 | Non-cytotoxic doses of shikonin inhibit lipopolysaccharide-induced TNF-α expression via activation of the AMP-activated protein kinase signaling pathway. | 2020 Nov | 1 |
5 | 24447680 | Shikonin inhibits the lipopolysaccharide-induced release of HMGB1 in RAW264.7 cells via IFN and NF-κB signaling pathways. | 2014 Mar | 1 |
6 | 23201088 | Shikonin ameliorates cerulein-induced acute pancreatitis in mice. | 2013 Jan 30 | 1 |
7 | 20423347 | Shikonin reduces oedema induced by phorbol ester by interfering with IkappaBalpha degradation thus inhibiting translocation of NF-kappaB to the nucleus. | 2010 May | 1 |